FINWIRES · TerminalLIVE
FINWIRES

Market Chatter: Japan Central Bank Assesses Rate Increase in June, Another One in 2026

By

The Japanese central bank's officers could look into a quarter-percentage-point rise in the policy rate in June, Bloomberg News reported Thursday, citing people familiar with the matter.

If pursued, the move could raise the benchmark interest rate to 1% at the central bank officials' meeting between June 15 and 16, according to the report's sources.

Another rate increase is also possible later this year, given still-low real interest rates and lingering upside inflation risks, the newswire's sources said.

A rate increase could meet some resistance, although this will not be enough to prevent the move, the report cited the people as saying.

Bank of Japan officials will also reconsider plans to reduce bond purchases, as they see less need to do so at the current pace, the report's sources said.

The yen performed better after the report, briefly hitting 159.61 against the dollar after floating above 160 earlier in the day, Bloomberg said.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Related Articles

Asia

Yankuang Energy to Renew Related-Party Deals

Yankuang Energy (HKG:1171, SHA:600188) agreed to renew its related-party deals with its controlling shareholder, Shandong Energy Group, until 2028, according to a Shanghai bourse disclosure on Wednesday.The transactions include the supply of materials and equipment, labor and services, the management of insurance funds, leasing deals and financial services.The annual threshold for this year's transactions was increased from the last year.The coal mining company's shares jumped 5% at the close.

$HKG:1171$SHA:600188
Asia

IndusInd Bank Denies Receiving Any Whistleblower Complaint Cited in Media Report

IndusInd Bank (NSE:INDUSINDBK, BOM:532187) said it has not received any communication from government or regulatory authorities regarding a whistleblower complaint mentioned in recent media reports, according to a Wednesday filing on Indian bourses.The clarification came after a media report suggested that a whistleblower complaint had been sent to the Prime Minister's Office and multiple regulators, including the Reserve Bank of India, the Serious Fraud Investigation Office, and the National Financial Reporting Authority. The report alleged insider trading, governance lapses, and issues in forensic and audit reviews following a 20-billion-rupee derivatives discrepancy.The bank said it has previously examined similar issues and has taken appropriate actions in line with its internal policies and regulatory requirements. It added that certain matters have also been proactively reported to relevant authorities and it continues to cooperate with regulators.

$BOM:532187$NSE:INDUSINDBK
Asia

China's Drug Regulator Accepts Marketing Application of Humanwell's Subsidiary for Landiolol Hydrochloride

China's National Medical Products Administration accepted the marketing application of Humanwell Healthcare's (SHA:600079) subsidiary, Yichang Humanwell Pharmaceutical, for landiolol hydrochloride for injection, according to a Shanghai bourse filing on Thursday.The drug is used for the treatment of tachyarrhythmias in patients with heart failure or during surgery.The pharmaceutical company invested 9.5 million yuan into the research and development of the drug.

$SHA:600079